Vaccine development services and vaccinology training
TransVac2 Newsletter November 2021
See TRANSVAC2 open calls for vaccine development services and vaccinology training. Read more
News
CfP: Fractional Dosing Platform Trial Approach launched on 7 Oct 2021
CEPI is pleased to announce a new funding opportunity for clinical trials with the aim to generate data on fractional doses of COVID-19 vaccines given as additional doses in primed populations. Read more
Largest ever Lassa fever study expands to more countries in West Africa
The largest ever study created and funded by the Coalition for Epidemic Preparedness Innovations (CEPI) to provide a more accurate assessment of the incidence of Lassa fever infections has launched in several more countries in West Africa. Read more
EDCTP and CEPI funding moves IAVI's Lassa fever vaccine candidate into advanced clinical development
IAVI has received an award of €22.8 million from the European & Developing Countries Clinical Trials Partnership (EDCTP) and the Coalition for Epidemic Preparedness Innovations (CEPI) to conduct a Phase IIb clinical trial of a novel vaccine candidate to prevent ... Read more
COVID-19: What Next?
COVID-19 has touched all of our lives and changed our world beyond recognition. What comes next? ... Read more
The International Vaccine Institute (IVI) in Seoul, Korea, is looking for experienced clinical trialists.
See more here... Read more
